Wnt Activation of Immortalized Brain Endothelial Cells as a Tool for Generating a Standardized Model of the Blood Brain Barrier In Vitro

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Paolinelli, Roberta ^a   Corada, Monica ^a   Ferrarini, Luca ^a   Devraj, Kavi ^c   Artus, Cédric ^d,e,f   Czupalla, Cathrin J ^c   Rudini, Noemi ^a   Maddaluno, Luigi ^a   Papa, Eleanna ^a   Engelhardt, Britta ^g   Couraud, Pierre Olivier ^d,e,f   Liebner, Stefan ^c   Dejana, Elisabetta ^a,b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c GOETHE UNIVERSITY   (Germany)

^d INSTITUT COCHIN   (France)

^e CNRS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYTOKINE; PROTEIN; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BIOTECHNOLOGY; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL CULTURE; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; DRUG INDUSTRY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; MOUSE; NONHUMAN; SCREENING; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIAL CELLS; MICE; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WNT PROTEINS;

EID: 84881180266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070233     Document Type: Article

References (74)

1. Engelhardt B, (2003) Development of the blood-brain barrier. Cell and tissue research 314: 119-129.
2. Hermann DM, Elali A, (2012) The abluminal endothelial membrane in neurovascular remodeling in health and disease. Science signaling 5: re4.
3. Liebner S, Czupalla CJ, Wolburg H, (2011) Current concepts of blood-brain barrier development. The International journal of developmental biology 55: 467-476.
4. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ, (2010) Structure and function of the blood-brain barrier. Neurobiology of disease 37: 13-25.
5. Kondoh M, Yoshida T, Kakutani H, Yagi K, (2008) Targeting tight junction proteins-significance for drug development. Drug discovery today 13: 180-186.
6. Pardridge WM, (2002) Why is the global CNS pharmaceutical market so under-penetrated? Drug discovery today 7: 5-7.
7. Gabathuler R, (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiology of disease 37: 48-57.
8. Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF, (2009) Getting into the brain: approaches to enhance brain drug delivery. CNS drugs 23: 35-58.
9. Begley DJ, (2004) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacology & therapeutics 104: 29-45.
10. Gumbleton M, Audus KL, (2001) Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. Journal of pharmaceutical sciences 90: 1681-1698.
11. Toth A, Veszelka S, Nakagawa S, Niwa M, Deli MA, (2011) Patented in vitro blood-brain barrier models in CNS drug discovery. Recent patents on CNS drug discovery 6: 107-118.
12. Wilhelm I, Fazakas C, Krizbai IA, (2011) In vitro models of the blood-brain barrier. Acta neurobiologiae experimentalis 71: 113-128.
13. Ribeiro MM, Castanho MA, Serrano I, (2010) In vitro blood-brain barrier models-latest advances and therapeutic applications in a chronological perspective. Mini reviews in medicinal chemistry 10: 262-270.
14. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, et al. (2009) Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 106: 641-646.
15. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, et al. (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322: 1247-1250.
16. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, et al. (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. The Journal of cell biology 183: 409-417.
17. Rohnelt RK, Hoch G, Reiss Y, Engelhardt B, (1997) Immunosurveillance modelled in vitro: naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. International immunology 9: 435-450.
18. Wagner EF, Risau W, (1994) Oncogenes in the study of endothelial cell growth and differentiation. Seminars in cancer biology 5: 137-145.
19. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 19: 1872-1874.
20. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, et al. (2010) The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PloS one 5: e13741.
21. Macdonald JA, Murugesan N, Pachter JS, (2010) Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. Journal of neuroscience research 88: 1457-1474.
22. Lyck R, Ruderisch N, Moll AG, Steiner O, Cohen CD, et al. (2009) Culture-induced changes in blood-brain barrier transcriptome: implications for amino-acid transporters in vivo. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 29: 1491-1502.
23. Garlanda C, Parravicini C, Sironi M, De Rossi M, Wainstok de Calmanovici R, et al. (1994) Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proceedings of the National Academy of Sciences of the United States of America 91: 7291-7295.
24. Balconi G, Spagnuolo R, Dejana E, (2000) Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arteriosclerosis, thrombosis, and vascular biology 20: 1443-1451.
25. Liebner S, Kniesel U, Kalbacher H, Wolburg H, (2000) Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. European journal of cell biology 79: 707-717.
26. Calabria AR, Weidenfeller C, Jones AR, de Vries HE, Shusta EV, (2006) Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. Journal of neurochemistry 97: 922-933.
27. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
28. Lluis F, Pedone E, Pepe S, Cosma MP, (2008) Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell stem cell 3: 493-507.
29. He X, Saint-Jeannet JP, Woodgett JR, Varmus HE, Dawid IB, (1995) Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 374: 617-622.
30. Pierce SB, Kimelman D, (1995) Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3. Development 121: 755-765.
31. Dominguez I, Itoh K, Sokol SY, (1995) Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proceedings of the National Academy of Sciences of the United States of America 92: 8498-8502.
32. Phiel CJ, Klein PS, (2001) Molecular targets of lithium action. Annual review of pharmacology and toxicology 41: 789-813.
33. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, et al. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry & biology 7: 793-803.
34. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, et al. (2003) GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chemistry & biology 10: 1255-1266.
35. Polychronopoulos P, Magiatis P, Skaltsounis AL, Myrianthopoulos V, Mikros E, et al. (2004) Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. Journal of medicinal chemistry 47: 935-946.
36. Spokoini R, Kfir-Erenfeld S, Yefenof E, Sionov RV, (2010) Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Molecular endocrinology 24: 1136-1150.
37. Vleminckx K, Kemler R, Hecht A, (1999) The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis. Mechanisms of development 81: 65-74.
38. Bao R, Christova T, Song S, Angers S, Yan X, et al. (2012) Inhibition of tankyrases induces axin stabilization and blocks wnt signalling in breast cancer cells. PloS one 7: e48670.
39. Bernas MJ, Cardoso FL, Daley SK, Weinand ME, Campos AR, et al. (2010) Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. Nature protocols 5: 1265-1272.
40. Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, et al. (2012) Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nature biotechnology 30: 783-791.
41. Steiner O, Coisne C, Engelhardt B, Lyck R, (2011) Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 31: 315-327.
42. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
43. Lampugnani MG, Zanetti A, Breviario F, Balconi G, Orsenigo F, et al. (2002) VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Molecular biology of the cell 13: 1175-1189.
44. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, et al. (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nature cell biology 10: 923-934.
45. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, et al. (2010) CCM1 regulates vascular-lumen organization by inducing endothelial polarity. Journal of cell science 123: 1073-1080.
46. Rempe R, Cramer S, Huwel S, Galla HJ, (2011) Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. Biochemical and biophysical research communications 406: 64-69.
47. Benson K, Cramer S, Galla HJ, (2013) Impedance-based cell monitoring: barrier properties and beyond. Fluids and barriers of the CNS 10: 5.
48. Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, et al. (1987) Molecular sieving characteristics of the cultured endothelial monolayer. Journal of cellular physiology 132: 111-117.
49. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology 3: RESEARCH0034.
50. Suzuki S, Sano K, Tanihara H, (1991) Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell regulation 2: 261-270.
51. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, et al. (1995) Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arteriosclerosis, thrombosis, and vascular biology 15: 1229-1239.
52. Morita K, Furuse M, Fujimoto K, Tsukita S, (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proceedings of the National Academy of Sciences of the United States of America 96: 511-516.
53. Schrade A, Sade H, Couraud PO, Romero IA, Weksler BB, et al. (2012) Expression and localization of claudins-3 and -12 in transformed human brain endothelium. Fluids and barriers of the CNS 9: 6.
54. Neuhaus W, Wirth M, Plattner VE, Germann B, Gabor F, et al. (2008) Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neuroscience letters 446: 59-64.
55. Sirotkin H, Morrow B, Saint-Jore B, Puech A, Das Gupta R, et al. (1997) Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. Genomics 42: 245-251.
56. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, et al. (2004) The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome research 14: 2121-2127.
57. Stan RV, Arden KC, Palade GE, (2001) cDNA and protein sequence, genomic organization, and analysis of cis regulatory elements of mouse and human PLVAP genes. Genomics 72: 304-313.
58. Carson-Walter EB, Hampton J, Shue E, Geynisman DM, Pillai PK, et al. (2005) Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clinical cancer research: an official journal of the American Association for Cancer Research 11: 7643-7650.
59. Seulberger H, Lottspeich F, Risau W, (1990) The inducible blood-brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. The EMBO journal 9: 2151-2158.
60. Unger CM, Seulberger H, Breier G, Albrecht U, Achen MG, et al. (1993) Expression of the HT7 gene in blood-brain barrier. Advances in experimental medicine and biology 331: 211-215.
61. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, et al. (2003) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449-459.
62. Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H, (1990) Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochemical and biophysical research communications 173: 67-73.
63. Albritton LM, Bowcock AM, Eddy RL, Morton CC, Tseng L, et al. (1992) The human cationic amino acid transporter (ATRC1): physical and genetic mapping to 13q12-q14. Genomics 12: 430-434.
64. Umeki N, Fukasawa Y, Ohtsuki S, Hori S, Watanabe Y, et al. (2002) mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME). Drug metabolism and pharmacokinetics 17: 367-373.
65. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, et al. (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 95: 15665-15670.
66. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, et al. (2003) The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 17: 2085-2087.
67. Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD, (1998) Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer research 58: 2741-2747.
68. Warren MS, Zerangue N, Woodford K, Roberts LM, Tate EH, et al. (2009) Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacological research: the official journal of the Italian Pharmacological Society 59: 404-413.
69. Ueda K, Clark DP, Chen CJ, Roninson IB, Gottesman MM, et al. (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. The Journal of biological chemistry 262: 505-508.
70. Schinkel AH, (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Advanced drug delivery reviews 36: 179-194.
71. Myklebost O, Arheden K, Rogne S, Geurts van Kessel A, Mandahl N, et al. (1989) The gene for the human putative apoE receptor is on chromosome 12 in the segment q13-14. Genomics 5: 65-69.
72. Deane R, Bell RD, Sagare A, Zlokovic BV, (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS & neurological disorders drug targets 8: 16-30.
73. Vissing H, Aagaard L, Tommerup N, Boel E, (1994) Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3. Genomics 24: 606-608.
74. Kehr NS, Prasetyanto EA, Benson K, Ergun B, Galstyan A, et al. (2013) Periodic mesoporous organosilica-based nanocomposite hydrogels as three-dimensional scaffolds. Angewandte Chemie 52: 1156-1160.